Agios Pharmaceuticals Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 08/07/2026 | 6.46 M | $239.58 M | 12.18% | 10.98% |
| FARALLON CAPITAL MANAGEMENT LLC | 08/14/2026 | 5.92 M | $219.59 M | 4.11% | 10.07% |
| STATE STREET CORP | 08/07/2026 | 3.53 M | $131.14 M | 5.02% | 6.01% |
| LYNX1 CAPITAL MANAGEMENT LP | 08/13/2026 | 3.41 M | $126.51 M | 30.53% | 5.80% |
| D. E. SHAW & CO., INC. | 08/14/2026 | 3.11 M | $115.30 M | 15.88% | 5.29% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 2.90 M | $107.55 M | 11.00% | 4.93% |
| ARMISTICE CAPITAL, LLC | 08/14/2026 | 2.81 M | $104.28 M | -12.19% | 4.78% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 2.68 M | $99.52 M | 1.88% | 4.56% |
| ARMISTICE CAPITAL, LLC | 08/14/2026 | 2.40 M | $89.06 M | -11.63% | 4.08% |
| ERSTE ASSET MANAGEMENT GMBH | 07/28/2026 | 2.15 M | $81.97 M | -20.33% | 3.67% |
| MACQUARIE MANAGEMENT HOLDINGS, INC. | 08/14/2026 | 2.11 M | $78.33 M | 41.24% | 3.59% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 1.57 M | $58.43 M | 7.25% | 2.68% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 1.38 M | $51.05 M | 2.28% | 2.34% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 08/14/2026 | 1.29 M | $47.80 M | 815.64% | 2.19% |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 08/13/2026 | 1.28 M | $47.50 M | -19.03% | 2.18% |
| DIMENSIONAL FUND ADVISORS LP | 08/11/2026 | 1.25 M | $46.35 M | 8.43% | 2.12% |
| GW&K INVESTMENT MANAGEMENT, LLC | 08/12/2026 | 1.21 M | $44.78 M | -0.68% | 2.05% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 1.15 M | $42.71 M | 42.84% | 1.96% |
| UBS GROUP AG | 08/13/2026 | 985.83 K | $36.58 M | 643.80% | 1.68% |
| MORGAN STANLEY | 08/13/2026 | 963.26 K | $35.75 M | -0.44% | 1.64% |
| NUVEEN, LLC | 08/11/2026 | 873.56 K | $32.42 M | 20.93% | 1.49% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 08/13/2026 | 810.53 K | $30.08 M | 223.62% | 1.38% |
| FORESITE CAPITAL MANAGEMENT VI LLC | 08/14/2026 | 785.00 K | $29.13 M | 49.52% | 1.34% |
| CITADEL ADVISORS LLC | 08/14/2026 | 732.69 K | $27.19 M | 18.25% | 1.25% |
| AQR CAPITAL MANAGEMENT LLC | 08/14/2026 | 684.34 K | $25.40 M | 1,779.54% | 1.16% |
| PARKMAN HEALTHCARE PARTNERS LLC | 08/14/2026 | 669.05 K | $24.83 M | 65.80% | 1.14% |
| SCS CAPITAL MANAGEMENT LLC | 08/06/2026 | 612.85 K | $22.74 M | 0.00% | 1.04% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2026 | 597.64 K | $22.18 M | 218.46% | 1.02% |
| NORTHERN TRUST CORP | 08/13/2026 | 554.71 K | $20.59 M | 8.92% | 0.94% |
| DEFILADE CAPITAL MANAGEMENT, L.P. | 08/14/2026 | 546.85 K | $20.29 M | 100.00% | 0.93% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 538.13 K | $19.97 M | 12.81% | 0.92% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 538.13 K | $19.97 M | 100.00% | 0.92% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 536.38 K | $19.91 M | 113.16% | 0.91% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 08/14/2026 | 532.56 K | $19.76 M | -33.36% | 0.91% |
| SCHONFELD STRATEGIC ADVISORS LLC | 08/14/2026 | 520.08 K | $19.30 M | 159.96% | 0.88% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 507.87 K | $18.85 M | -0.01% | 0.86% |
| POINT72 ASSET MANAGEMENT, L.P. | 08/14/2026 | 506.34 K | $18.79 M | 100.00% | 0.86% |
| JANE STREET GROUP, LLC | 08/14/2026 | 492.60 K | $18.28 M | -28.11% | 0.84% |
| LEGAL & GENERAL GROUP PLC | 08/14/2026 | 434.72 K | $16.13 M | 2.55% | 0.74% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 395.87 K | $14.69 M | 3.62% | 0.67% |
| PANAGORA ASSET MANAGEMENT INC | 08/06/2026 | 373.93 K | $13.88 M | 56.81% | 0.64% |
| KENNEDY CAPITAL MANAGEMENT LLC | 08/14/2026 | 373.23 K | $13.85 M | 35.50% | 0.63% |
| JPMORGAN CHASE & CO | 08/12/2026 | 359.76 K | $13.78 M | 137.37% | 0.61% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 08/13/2026 | 359.55 K | $13.34 M | -20.12% | 0.61% |
| SQUAREPOINT OPS LLC | 08/14/2026 | 321.14 K | $11.92 M | 53.74% | 0.55% |
| ENSIGN PEAK ADVISORS, INC | 08/14/2026 | 297.63 K | $11.05 M | 4,430.14% | 0.51% |
| BNP PARIBAS ARBITRAGE, SNC | 08/13/2026 | 269.38 K | $10.00 M | -17.73% | 0.46% |
| ALGERT GLOBAL LLC | 08/13/2026 | 248.01 K | $9.20 M | -7.61% | 0.42% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2026 | 218.97 K | $8.13 M | -26.71% | 0.37% |
| JANE STREET GROUP, LLC | 08/14/2026 | 214.90 K | $7.97 M | 100.65% | 0.37% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Agios Pharmaceuticals Inc institutional Ownership - FAQ's
During the previous two years, 357 institutional investors and hedge funds held shares of Agios Pharmaceuticals Inc. The most heavily invested institutionals were:
BlackRock, Inc.: 6.46 M
FARALLON CAPITAL MANAGEMENT LLC: 5.92 M
STATE STREET CORP: 3.53 M
Lynx1 Capital Management LP: 3.41 M
D. E. Shaw & Co., Inc.: 3.11 M
VANGUARD PORTFOLIO MANAGEMENT LLC: 2.9 M
113.04% of Agios Pharmaceuticals Inc stock is owned by institutional investors.
Institutional investors have bought a total of 91.21 M shares in the last 24 months. This purchase volume represents approximately $2.60 B in transactions.